Transfection Reagents And Equipment Market Forecast Highlights Expansion From $1.93 Billion To $2.96 Billion Through 2030
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
The market for transfection reagents and equipment has witnessed significant expansion recently, driven by advances in molecular biology and biopharmaceutical research. As scientific exploration and technology continue to evolve, this sector is poised for strong growth through 2030. Below, we explore the market’s size, growth factors, key segments, innovations, leading players, and regional dynamics shaping its future.
Steady Growth Trajectory in the Transfection Reagents and Equipment Market
The market value for transfection reagents and equipment is on the rise, moving from $1.74 billion in 2025 to $1.93 billion in 2026, reflecting an impressive compound annual growth rate (CAGR) of 11.2%. This earlier expansion has been largely propelled by heightened molecular biology research, increased use of cell-based assays, the surge in recombinant protein production, expanded genomics research in both academic and industrial settings, and access to advanced transfection chemistries.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10780&type=smp
Forecasted Market Expansion Driven by Cutting-Edge Research
Looking ahead, the transfection reagents and equipment market is expected to grow rapidly, reaching $2.97 billion by 2030 with a CAGR of 11.3%. This anticipated rise is fueled by wider adoption of CRISPR and gene therapy techniques, an increasing need for scalable transfection platforms, growth in the biopharmaceutical development pipeline, greater investment in precision medicine initiatives, and automation trends in life sciences laboratories. Prominent trends shaping this growth include greater use of high-efficiency transfection reagents, gene-editing compatible delivery systems, non-viral transfection methods, automated transfection instruments, and cell-type specific transfection solutions.
Growing Cancer Incidence Acts as a Market Growth Catalyst
One of the main factors driving this market is the worldwide increase in cancer cases. Cancer, characterized by uncontrolled cell growth, heavily relies on transfection reagents in research for introducing genetic material like plasmid DNA or RNA molecules. This enables studies on gene expression, gene silencing, drug screening, and target validation. For example, projections from Cancer Research UK in July 2024 indicate rising cancer incidence rates for most types in the UK between 2023-2025 and 2038-2040, with increases ranging from under 1% for breast cancer to as much as 50% for eye cancer. This trend highlights the growing demand for transfection reagents within cancer research.
Access The Complete Transfection Reagents And Equipment Market Report:
The Transfection Reagents and Equipment Market’s Core Segmentation
This market is broken down into several important segments:
1) By Product Category: Instruments, Reagents, and Kits
2) By Molecule Type: Plasmid DNA, DNA Oligonucleotides, Small Interfering RNA (SiRNA), Proteins, Ribonucleoprotein Complexes (RNPs), and other molecules
3) By End User: Biopharmaceutical companies, Contract Research Organizations (CROs), and Academic institutions
Further subcategories include:
– Instruments such as Electroporation Systems, Microinjection Systems, and Particle Bombardment Systems
– Reagents and Kits including Lipid-Based, Polymer-Based, Protein-Based Transfection Reagents, and Nucleic Acid Delivery Kits
Innovations Shaping the Transfection Reagents and Equipment Market
Leading companies are pushing the envelope by developing advanced products like GMP-grade AAV transfection reagents aimed at enhancing viral vector production efficiency for gene therapy manufacturing. These reagents comply with regulatory standards and enable high-efficiency genetic delivery into suspension cell cultures for scalable recombinant adeno-associated virus vector production. For instance, in July 2025, Yeasen Biotechnology from China received FDA Drug Master File acceptance for its UltraAAV PEI Transfection Reagent—GMP grade, noted for producing higher viral titers and improved full capsid ratios across multiple AAV serotypes. This advancement supports more efficient manufacturing with less reagent use while meeting stringent clinical and commercial quality standards.
Prominent Market Participants Steering Industry Progress
Key players holding significant market positions include Thermo Fisher Scientific Inc., Promega Corporation, Qiagen N.V., Bio-Rad Laboratories Inc., MaxCyte Inc., Lonza Group Ltd., Merck KGaA, Mirus Bio LLC, OriGene Technologies Inc., Altogen Biosystems, Applied Biological Materials Inc., Bex Co. Ltd., Takara Bio Inc., Polyplus-transfection SA, Sigma-Aldrich Corporation, Transfection Technologies Inc., Viromer, ABM Inc., chemicell GmbH, Genlantis, Biontech Laboratories GmbH, Jena Bioscience GmbH, PromoCell GmbH, PerkinElmer Inc., Sartorius AG, Hoffmann-La Roche Ltd., Bio-Techne Corporation, Biotium Inc., and Cell Applications Inc.
Regional Market Leadership and Growth Outlook
In 2025, North America held the largest share of the transfection reagents and equipment market. However, the Asia-Pacific region is set to experience the fastest growth over the forecast period. The geographic analysis in the market report includes regions such as Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a broad view of global market developments.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
